OGN (OGN)

$13.38
+0.15%
$3.5B
Market Cap
14.3
P/E Ratio
1.55
Beta
0.60%
Dividend Yield
Piotroski 5/9Altman Z 1.1 DistressBeneish M -2.66 CleanROIC−WACC +1.0%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.1.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of OGN presents a mixed fundamental profile characterized by high leverage driving returns rather than operational scale. While the DuPont decomposition reveals that an equity multiplier of 17.11x is the primary engine behind the 24.9% ROE, this aggressive financial structure yields only a modest +1.0% spread between its 7.0% ROIC and 6.0% WACC, indicating limited value creation beyond cost of capital. Credit risk metrics are notably concerning; an Altman Z-Score of 1.1 signals potential distress territory, contrasting sharply with the negative Beneish M-Score of -2.66 which suggests low earnings manipulation risk but fails to offset solvency concerns. Operational momentum is further dampened by a contraction in revenue growth of -2.9% YoY and a relatively weak Piotroski F-Score of 5/9, suggesting the company lacks the financial strength or profitability improvements typically associated with high-quality issuers despite maintaining healthy gross margins near 53%.

Valuation metrics appear compressed relative to historical norms and sector peers, trading at a P/E multiple of 12.3x that may reflect market skepticism regarding its debt-heavy balance sheet rather than pure value opportunity. The DCF analysis implies an intrinsic fair value of $13, suggesting the current price could be undervalued if future cash flows stabilize; however, this model relies on significant assumptions to overcome the headwinds presented by negative revenue growth and a narrow ROIC-WACC spread. Essentially, the market is pricing in substantial downside risk from potential liquidity constraints while simultaneously acknowledging that the low multiple might offer a margin of safety contingent on successful deleveraging or operational turnaround.

Risk assessment highlights a dichotomy between credit fragility and earnings integrity. The distressed Altman Z-Score introduces significant tail risk regarding solvency, whereas the negative Beneish M-Score provides some confidence in reported net margins despite the shrinking top line. With insider flow remaining neutral over the last 90 days, there is no clear signal of management conviction or distress selling to guide sentiment. The investment thesis hinges entirely on whether the market can sustain this high-leverage model without triggering a credit event that would invalidate current valuation assumptions.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive
Market Price
$13.38
Fair Value
$13
Implied Upside
-2.5%
$13IMPLIED FAIR VALUEFAIRLY VALUEDOVERUNDER
Growth Rate (Y1–5)0%
-10%20%50%
Discount Rate (WACC)6.0%
5%12.5%20%

5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.

Sensitivity Matrix

TG ↓ / WACC →6%6%8%
2%$3$3$0
3%$13$13$0
4%$32$32$1

Center = base case. Green = >10% upside, Red = >10% downside vs $13.38.

Pre-computed DCF: WACC=6.0%, terminal growth 3%. Fair value $13 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.1
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.66
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

53.3%
Gross Margin
3.0%
Net Margin
7.0%
ROIC
6.0%
WACC
ROIC − WACC Spread: +1.0%— Positive spread.
-2.9%
Revenue Growth (YoY)
-78.4%
Earnings Growth (YoY)
384.0M
Free Cash Flow
23%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

3.0%
Net Profit Margin
NI ÷ Revenue
×
0.48x
Asset Turnover
Revenue ÷ Assets
×
17.11x
Equity Multiplier
Assets ÷ Equity
=
24.9%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

16.11x
Debt / Equity
1.82x
Current Ratio
1.8x
Interest Coverage
6.2x
Net Debt / EBITDA
3.71%
FCF Yield
1.3B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.89
Act: $1.02
+14.2%
Q3
✓ Beat
Est: $0.94
Act: $1.00
+6.4%
Q2
✓ Beat
Est: $0.93
Act: $1.01
+8.5%
Q1
✗ Miss
Est: $0.73
Act: $0.63
-13.3%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Dividend History

$0.0200
Latest Dividend
$0.34
2025 Total
-69.6%
YoY Growth
Annual Dividends per Share
$0.56
2021
$1.12
2022
$1.12
2023
$1.12
2024
$0.34
2025
$0.04
2026
DateAmountChange
2026-05-11$0.02000.0%
2026-02-23$0.02000.0%
2025-11-20$0.02000.0%
2025-08-15$0.02000.0%
2025-05-12$0.0200-92.9%
2025-02-24$0.28000.0%
2024-11-12$0.28000.0%
2024-08-16$0.28000.0%
2024-05-10$0.28000.0%
2024-02-23$0.28000.0%
2023-11-10$0.28000.0%
2023-08-17$0.28000.0%

Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

3.6
Forward P/E
PEG Ratio
3.88
Price/Book
9M
Avg Volume
$13.48
52W High
$5.69
52W Low
99%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$130M
Tracked Passive Exposure
8
ETFs Holding OGN
0.06%
Avg Weight in ETFs
$202B
Total ETF AUM

When investors buy or sell ETFs like XPH or SLYV, the fund manager is mechanically forced to buy or sell OGN shares regardless of OGN's individual fundamentals. We estimate $130M of passive capital is structurally linked to OGN through 8 tracked ETFs. Passive flows have a limited but growing influence on OGN's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in OGN to visualize passive redemption contagion across ETFs and collateral stocks.

OGN Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
OGNEpicenterVYMETFVBRETFVHTETFCORTLow RiskLQDAUnknownRPRXMed RiskVTRSUnknownAXSMUnknown
OGN Price Drop (%)0

If OGN (OGN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies CORCEPT THERAPEUTICS INC (CORT) as the most exposed collateral stock, sharing 2 ETFs with OGN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 9 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

OGN Ownership Dynamics

Passive funds hold 1 in every 25 OGN shares, reducing daily market volatility.

Ticker
OGN
Total Shares
263M
ETF Lock-Up
4.1%
Display Mode
Total Float Impact
4.1%Locked Float

OGN (OGN) exerts measurable gravity on the passive index market, currently representing 3.8% of the XPH (XPH) and 0.4% of the SLYV (SLYV). Across 9 tracked ETFs, approximately 11M shares (4.1% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.

Float lock-up computed from 9 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

OGN Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
OGN
PRICE
$13.38
FLOOR (POC)
$13.29
STRENGTH
High
$6$6$76%$79%$78%$8$86%$9$98%$99%$108%$10$11$11$11$12$12$13$13$13POC 20%$13.38
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for OGN over the past year sits near $13.29 (20% of 252-day volume). The current price of $13.38 trades 0.7% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (20% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

OGN Capital Efficiency

How efficiently does OGN convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$384M
EBITDA
$1.3B
FCF Conversion
30%
Reinvestment Rate
70%
30% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
7.0%
ROIC − WACC Spread
1.0%

OGN converts 30% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 70% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 1.0% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-143$13.34$40.02
2026-05-13638$13.31$8,491.78
2026-05-1264$13.33$853.12
2026-05-1111,054$13.35$147,570.9
2026-05-08295$13.32$3,929.4
2026-05-071,249$13.41$16,749.09
2026-05-066,476$13.35$86,454.6
2026-05-05891$13.26$11,814.66
2026-05-0426$13.29$345.54
2026-05-01254$13.25$3,365.5
2026-04-2939,608$13.32$527,578.56
2026-04-28219,881$13.16$2.9M
2026-04-2720,071$11.26$225,999.46
2026-04-2312$9.14$109.68
2026-04-175,407$9.33$50,447.31
2026-04-15565$8.70$4,915.5
2026-04-139,291$8.83$82,039.53
2026-04-0710$6.05$60.5
2026-04-0610$6.36$63.6
2026-03-31443$5.70$2,525.1
2026-03-301,065$5.84$6,219.6
2026-03-2512$6.11$73.32
2026-03-231,006$6.03$6,066.18
2026-03-19318$6.23$1,981.14
2026-03-162,021$6.35$12,833.35
2026-03-126,836$6.40$43,750.4
2026-03-1110,799$6.48$69,977.52
2026-03-04405$6.90$2,794.5
2026-02-2558$8.14$472.12
2026-02-233,110$8.10$25,191

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare OGN to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.